A

네오팜

092730KOSDAQ기타 화학제품 제조업

70.3 / 100

Reference Date: 2026-04-13

Financial Score31.0 / 40
News Sentiment21.3 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and ROE significantly exceeds the industry average is also solid. Slightly down 2.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Neoparm operates various cosmetics brands, including its flagship 'Atopear', and achieved sales of 132.1 billion KRW and net profit of 27.9 billion KRW in 2025. The company leverages its proprietary MLE formulation technology, which enhances skin barrier function, securing market competitiveness. 'Atopear' has maintained the top position in the sensitive skincare category for 19 consecutive years according to the K-BPI survey.

Number of Employees

192people

Average Salary

63.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
9.65Industry Average 18.386.5Point

Lower than industry avg (good)

PBR
1.41Industry Average 1.372.5Point

Higher than industry avg (caution)

ROE
14.95Industry Average 4.557.0Point

3.3x industry avg (excellent)

Debt Ratio
0.73Industry Average 8.138.0Point

Half of industry avg (excellent)

Trend 2023~20257.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲16.8% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲7.1% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 14.7% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position5.0Point

52w mid range (48%)

Current 17,170Won52-week high 21,70052-week low 12,970
1-month return2.0Point

1m -2.66% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral주식등의대량보유상황보고서(약식)2026-04-01
  • Neutral기업가치제고계획(자율공시)2026-03-25
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-24
  • Neutral정기주주총회결과2026-03-24
  • Neutral사업보고서 (2025.12)2026-03-16